You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TVTX Sale Disclosure
Calvin Sandra · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$265.63K
Calvin Sandra SVP, Chief Accounting Officer
TVTX
Travere Therapeutics
TVTX
Transaction date
Sep 15, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 2 days later
TVTX daily price context
Close on/before transaction
$62.51
Sep 15, 2026
First close after public filing
$62.76
Sep 18, 2026
30-day return after filing
-19.55%
Through Oct 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,275 shares @ $62.13
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001882909-26-000004
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$465K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $68.75K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $28K |
| Travere Therapeutics, Inc. TVTX Current | Sale | Sep 15, 2026 | $265.63K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $50.28K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $19.1K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $33.25K |